GeneDx Holdings Corp. Warrant lost $0.73 per diluted share in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters GeneDx Holdings Corp. Warrant has filed alongside them.
FY2025 annual
EPS (Diluted)-$0.73
YoYn/m
Source SEC Filings (10-K/10-Q)Latest period Q1 FY2026, ended Mar 31, 2026ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
WGSWW EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
GeneDx Holdings Corp. Warrant lost $0.73 per diluted share in fiscal year 2025.
GeneDx Holdings Corp. Warrant (WGSWW) reported a loss of $1.94 per diluted share in fiscal year 2024 and a loss of $0.73 per diluted share in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Across the 7 fiscal years this page covers, GeneDx Holdings Corp. Warrant (WGSWW) diluted earnings per share went from -$264056.00 in fiscal year 2019 to -$0.73 in fiscal year 2025.
GeneDx Holdings Corp. Warrant (WGSWW) reported -$2.16 in diluted earnings per share in Q1 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what GeneDx Holdings Corp. Warrant (WGSWW) reported on that line in every period on record.
